Published in Neuron on February 01, 1993
Reevaluation of Drosophila melanogaster's neuronal circadian pacemakers reveals new neuronal classes. J Comp Neurol (2006) 1.71
A genetic and molecular analysis of the 46C chromosomal region surrounding the FMRFamide neuropeptide gene in Drosophila melanogaster. Genetics (1994) 1.01
Analysis of neuropeptide expression and localization in adult drosophila melanogaster central nervous system by affinity cell-capture mass spectrometry. J Proteome Res (2009) 0.96
Identification in Drosophila melanogaster of the invertebrate G protein-coupled FMRFamide receptor. Proc Natl Acad Sci U S A (2002) 0.96
Temporally tuned neuronal differentiation supports the functional remodeling of a neuronal network in Drosophila. Proc Natl Acad Sci U S A (2012) 0.84
Novel Genes Involved in Controlling Specification of Drosophila FMRFamide Neuropeptide Cells. Genetics (2015) 0.79
Subtype-specific neuronal remodeling during Drosophila metamorphosis. Fly (Austin) (2013) 0.77
The study of the Bithorax-complex genes in patterning CCAP neurons reveals a temporal control of neuronal differentiation by Abd-B. Biol Open (2015) 0.75
A pdf neuropeptide gene mutation and ablation of PDF neurons each cause severe abnormalities of behavioral circadian rhythms in Drosophila. Cell (1999) 5.14
The cost-effectiveness of sildenafil. Ann Intern Med (2000) 3.62
Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev (1995) 3.16
Inquiry about victimization experiences. A survey of patient preferences and physician practices. Arch Intern Med (1992) 3.11
Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA (1994) 2.83
Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther (2001) 2.69
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Systemic absorption of sunscreen after topical application. Lancet (1997) 2.36
Neuropeptides and neuropeptide receptors in the Drosophila melanogaster genome. Genome Res (2001) 2.28
Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care (2007) 2.06
The log-linear relationship between sexual isolation and sequence divergence in Bacillus transformation is robust. Genetics (1995) 2.00
Unsustained multiplication of treponema pallidum (nichols virulent strain) in vitro in the presence of oxygen. Infect Immun (1978) 1.80
Nucleosome positioning on the MMTV LTR results from the frequency-biased occupancy of multiple frames. Genes Dev (1995) 1.74
Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. J Antimicrob Chemother (2006) 1.70
Relationship of Bacillus subtilis clades associated with strains 168 and W23: a proposal for Bacillus subtilis subsp. subtilis subsp. nov. and Bacillus subtilis subsp. spizizenii subsp. nov. Int J Syst Bacteriol (1999) 1.51
Subcutaneous fluid administration in elderly subjects: validation of an under-used technique. J Am Geriatr Soc (1991) 1.49
Cost effectiveness of vaccination strategies in adults without a history of chickenpox. Am J Med (2000) 1.49
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats. J Lab Clin Med (1998) 1.44
Genetic analysis of the Drosophila ellipsoid body neuropil: organization and development of the central complex. J Neurobiol (1999) 1.44
A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons. J Neurol Neurosurg Psychiatry (2005) 1.44
Management of asymptomatic gallstones in the diabetic patient. A decision analysis. Ann Intern Med (1988) 1.40
Prescriptions, practitioners and pharmacists. Med J Aust (1998) 1.39
Sunscreens: are Australians getting the good oil? Aust N Z J Med (1998) 1.39
Sociodemographic differences in early access to liver transplantation services. Am J Transplant (2009) 1.30
Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol (1982) 1.27
Autonomic function and human immunodeficiency virus infection. Neurology (1990) 1.26
Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther (1994) 1.25
The cryptocephal gene (ATF4) encodes multiple basic-leucine zipper proteins controlling molting and metamorphosis in Drosophila. Genetics (2000) 1.23
Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VII. J Biol Chem (2001) 1.23
PHM is required for normal developmental transitions and for biosynthesis of secretory peptides in Drosophila. Dev Biol (2000) 1.22
Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab (1997) 1.20
Isolation and characterization of a Drosophila gene that encodes multiple neuropeptides related to Phe-Met-Arg-Phe-NH2 (FMRFamide). Proc Natl Acad Sci U S A (1988) 1.18
Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci (2001) 1.17
Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol (2008) 1.16
A peritracheal neuropeptide system in insects: release of myomodulin-like peptides at ecdysis. J Exp Biol (1998) 1.13
Cell type-specific regulation of the Drosophila FMRF-NH2 neuropeptide gene by Apterous, a LIM homeodomain transcription factor. Development (1998) 1.13
Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation. J Neurosci (1997) 1.11
Self-restraint: a review of etiology and applications in mentally retarded adults with self-injury. Res Dev Disabil (1991) 1.10
Disappearance kinetics of solutes from synovial fluid after intra-articular injection. Br J Clin Pharmacol (1994) 1.08
Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J Chromatogr (1981) 1.08
Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol (2009) 1.08
A rapid method for determination of acetylation phenotype using dapsone. Br J Clin Pharmacol (1984) 1.07
Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur J Immunol (1998) 1.07
Cell determination and regulation during development of neuroblasts and neurones in grasshopper embryo. Nature (1984) 1.07
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog. J Toxicol Clin Toxicol (1993) 1.06
A survey of self-restraint, self-injury, and other maladaptive behaviors in an institutionalized retarded population. Res Dev Disabil (1989) 1.05
Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
A genetic and molecular analysis of the 46C chromosomal region surrounding the FMRFamide neuropeptide gene in Drosophila melanogaster. Genetics (1994) 1.01
Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev (2001) 1.01
Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol (1985) 1.00
Antigenic heterogeneity of human immunoglobulin A proteins. Science (1966) 1.00
Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv (2004) 0.99
Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. Br J Clin Pharmacol (1999) 0.99
Distribution of microbial communities associated with the dominant high marsh plants and sediments of the United States East Coast. Microb Ecol (2004) 0.98
Functional redundancy of FMRFamide-related peptides at the Drosophila larval neuromuscular junction. J Neurosci (1998) 0.98
Functional capacity and treatment data from a community based study of patients with rheumatoid arthritis. Ann Rheum Dis (1986) 0.97
High-performance liquid chromatographic assay for common sunscreening agents in cosmetic products, bovine serum albumin solution and human plasma. J Chromatogr B Biomed Appl (1996) 0.96
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations. J Pharmacokinet Biopharm (1986) 0.95
Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats. J Pharm Pharmacol (1995) 0.95
Guidance of pioneer growth cones: filopodial contacts and coupling revealed with an antibody to Lucifer Yellow. Dev Biol (1982) 0.94
Oligodendrocyte degeneration and recovery after focal cerebral ischemia. Neuroscience (2010) 0.94
Local deep tissue penetration of compounds after dermal application: structure-tissue penetration relationships. J Pharmacol Exp Ther (1996) 0.94
Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharm Sci (1994) 0.93
An optimized model for rat liver perfusion studies. J Surg Res (1996) 0.92
Factors associated with diagnosis and treatment of osteoporosis in older adults. Osteoporos Int (2009) 0.92
An immunocytochemical study of the FMRFamide neuropeptide gene products in Drosophila. J Comp Neurol (1993) 0.92
In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Pharm Res (1996) 0.91
A quantitative assessment of limited joint mobility in patients with diabetes. Goniometric analysis of upper extremity passive range of motion. Arthritis Rheum (1993) 0.91
Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol (1977) 0.91
Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther (2006) 0.91
Topical bioavailability of methyl salicylate. Aust N Z J Med (1982) 0.91
Cell determination and differentiation of identified serotonin-immunoreactive neurons in the grasshopper embryo. J Neurosci (1984) 0.90
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clin Microbiol Infect (2014) 0.90
Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster. J Biol Chem (1998) 0.90
Interaction of Drosophila melanogaster prohormone convertase 2 and 7B2. Insect cell-specific processing and secretion. J Biol Chem (2000) 0.90
The effect of iontophoresis and vehicle pH on the in-vitro permeation of lignocaine through human stratum corneum. J Pharm Pharmacol (1985) 0.90
Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology (1998) 0.89
Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. Blood (1999) 0.89
Can increasing the viscosity of formulations be used to reduce the human skin penetration of the sunscreen oxybenzone? J Invest Dermatol (2001) 0.89
Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J Pharmacol Exp Ther (2001) 0.89
Spectral analysis of heart rate in diabetic autonomic neuropathy. A comparison with standard tests of autonomic function. Arch Neurol (1991) 0.88
Lunar phases and psychiatric hospital admissions. Psychol Rep (1994) 0.88
Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab (1996) 0.88
Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. Skin Pharmacol Physiol (2005) 0.88
Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol (1998) 0.88
The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders. Eur J Clin Pharmacol (1986) 0.88
Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies. Eur J Clin Pharmacol (1984) 0.87
The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. Br J Clin Pharmacol (1985) 0.87
Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals. Res Virol (1995) 0.87
Characterization of microbial and chemical composition of shuttle wet waste with permanent gas and volatile organic compound analyses. Adv Space Res (2004) 0.87
Development of the enteric nervous system in the moth. I. Diversity of cell types and the embryonic expression of FMRFamide-related neuropeptides. Dev Biol (1989) 0.86
The effect of occlusion on epidermal penetration of parabens from a commercial allergy test ointment, acetone and ethanol vehicles. J Invest Dermatol (2000) 0.86
Effect of posture and sleep on pharmacokinetics. I. Amoxycillin. Eur J Clin Pharmacol (1980) 0.85
Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer (2001) 0.85
Toward a peer review process for medical decision analysis models. Med Care (1994) 0.85
Origins of the insect enteric nervous system: differentiation of the enteric ganglia from a neurogenic epithelium. Development (1991) 0.85
Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Pharmacokinet Biopharm (1993) 0.85